Sumitomo Pharmaceuticals Company Limited

Dainippon Sumitomo Pharma Co., Ltd.

Yoshihide Ueno

Naohito Ohashi

Masami Muraoka

Koji Morishita

Fumio Nishikaku

Masashi Nakatsuka

Nobuyuki Sawada

Takashi Umezome

Tsuyoshi Noguchi

Kotaro Hirota

Shin-ichiro Okada

The compound of the formula (I): wherein W is a group of the following formula (VIII) binding to any possible position on the Q: Q is, together with W, a group of the formula: &#x2014;C(W)&#x2550;C(R)&#x2014;N(R)&#x2014;, etc.; Ris H or optionally substituted lower alkyl; R, R, R, and Rare independently H or optionally substituted lower alkyl; Ris optionally substituted lower alkyl, etc.; Ris H, etc.; Ris H, etc.; Ar is phenyl, etc., or a pharmaceutically acceptable salt thereof, where these compounds exhibiting &#x3b2;3-adrenoceptor-stimulating activity and being useful as a medicament for treatment of obesity, etc.

Indole, indazole, and benzazole derivative

LDL receptor gene expression promoters

An isoxazole derivative represented by the formula: ##STR1## or a pharmaceutically acceptable salt thereof useful as a therapeutic drug for auto-immune diseases and inflammatory diseases.

Isoxazole derivatives

Growing community of inventors

Osaka, Japan

Yoshihide Ueno